請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40418
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林文澧 | |
dc.contributor.author | Sheng-Kai Wu | en |
dc.contributor.author | 吳聖凱 | zh_TW |
dc.date.accessioned | 2021-06-14T16:47:08Z | - |
dc.date.available | 2010-08-06 | |
dc.date.copyright | 2008-08-06 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-31 | |
dc.identifier.citation | [1] R. A. Hawkins, D. R. Peterson, and J. R. Vina, 'The complementary membranes forming the blood-brain barrier,' IUBMB Life, vol. 54, pp. 101-7, Sep 2002.
[2] S. I. Rapoport, 'Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications,' Cell Mol Neurobiol, vol. 20, pp. 217-30, Apr 2000. [3] J. T. Patrick, M. N. Nolting, S. A. Goss, K. A. Dines, J. L. Clendenon, M. A. Rea, and R. F. Heimburger, 'Ultrasound and the blood-brain barrier,' Adv Exp Med Biol, vol. 267, pp. 369-81, 1990. [4] K. Y. Ng, C. W. Cho, T. K. Henthorn, and R. L. Tanguay, 'Effect of heat preconditioning on the uptake and permeability of R123 in brain microvessel endothelial cells during mild heat treatment,' J Pharm Sci, vol. 93, pp. 896-907, Apr 2004. [5] H. Tang, C. C. Wang, D. Blankschtein, and R. Langer, 'An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport,' Pharm Res, vol. 19, pp. 1160-9, Aug 2002. [6] L. Bakay, H. T. Ballantine, Jr., T. F. Hueter, and D. Sosa, 'Ultrasonically produced changes in the blood-brain barrier,' AMA Arch Neurol Psychiatry, vol. 76, pp. 457-67, Nov 1956. [7] K. Hynynen, N. McDannold, N. Vykhodtseva, and F. A. Jolesz, 'Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits,' Radiology, vol. 220, pp. 640-6, Sep 2001. [8] K. Hynynen, N. McDannold, N. Vykhodtseva, and F. A. Jolesz, 'Non-invasive opening of BBB by focused ultrasound,' Acta Neurochir Suppl, vol. 86, pp. 555-8, 2003. [9] N. Sheikov, N. McDannold, N. Vykhodtseva, F. Jolesz, and K. Hynynen, 'Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles,' Ultrasound Med Biol, vol. 30, pp. 979-89, Jul 2004. [10] K. Hynynen, N. McDannold, N. A. Sheikov, F. A. Jolesz, and N. Vykhodtseva, 'Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications,' Neuroimage, vol. 24, pp. 12-20, Jan 1 2005. [11] N. McDannold, N. Vykhodtseva, S. Raymond, F. A. Jolesz, and K. Hynynen, 'MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits,' Ultrasound Med Biol, vol. 31, pp. 1527-37, Nov 2005. [12] K. Hynynen, N. McDannold, N. Vykhodtseva, S. Raymond, R. Weissleder, F. A. Jolesz, and N. Sheikov, 'Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery,' J Neurosurg, vol. 105, pp. 445-54, Sep 2006. [13] M. Kinoshita, N. McDannold, F. A. Jolesz, and K. Hynynen, 'Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption,' Proc Natl Acad Sci U S A, vol. 103, pp. 11719-23, Aug 1 2006. [14] M. Kinoshita, N. McDannold, F. A. Jolesz, and K. Hynynen, 'Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound,' Biochem Biophys Res Commun, vol. 340, pp. 1085-90, Feb 24 2006. [15] N. McDannold, N. Vykhodtseva, and K. Hynynen, 'Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity,' Phys Med Biol, vol. 51, pp. 793-807, Feb 21 2006. [16] N. Sheikov, N. McDannold, F. Jolesz, Y. Z. Zhang, K. Tam, and K. Hynynen, 'Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier,' Ultrasound Med Biol, vol. 32, pp. 1399-409, Sep 2006. [17] K. Hynynen, 'Focused ultrasound for blood-brain disruption and delivery of therapeutic molecules into the brain,' Expert Opin Drug Deliv, vol. 4, pp. 27-35, Jan 2007. [18] N. McDannold, N. Vykhodtseva, and K. Hynynen, 'Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study,' Ultrasound Med Biol, vol. 33, pp. 584-90, Apr 2007. [19] S. B. Raymond, J. Skoch, K. Hynynen, and B. J. Bacskai, 'Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo,' J Cereb Blood Flow Metab, vol. 27, pp. 393-403, Feb 2007. [20] L. H. Treat, N. McDannold, N. Vykhodtseva, Y. Zhang, K. Tam, and K. Hynynen, 'Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound,' Int J Cancer, vol. 121, pp. 901-7, Aug 15 2007. [21] N. McDannold, N. Vykhodtseva, and K. Hynynen, 'Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption,' Ultrasound Med Biol, vol. 34, pp. 930-7, Jun 2008. [22] N. McDannold, N. Vykhodtseva, and K. Hynynen, 'Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index,' Ultrasound Med Biol, vol. 34, pp. 834-40, May 2008. [23] N. Sheikov, N. McDannold, S. Sharma, and K. Hynynen, 'Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium,' Ultrasound Med Biol, vol. 34, pp. 1093-104, Jul 2008. [24] N. Vykhodtseva, N. McDannold, and K. Hynynen, 'Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison,' Ultrasound Med Biol, vol. 32, pp. 1923-9, Dec 2006. [25] F. Y. Yang, W. M. Fu, W. S. Chen, W. L. Yeh, and W. L. Lin, 'Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption,' Ultrason Sonochem, vol. 15, pp. 636-43, Apr 2008. [26] S. D. Sokka, T. P. Gauthier, and K. Hynynen, 'Theoretical and experimental validation of a dual-frequency excitation method for spatial control of cavitation,' Phys Med Biol, vol. 50, pp. 2167-79, May 7 2005. [27] P. Z. He, R. M. Xia, S. M. Duan, W. D. Shou, and D. C. Qian, 'The affection on the tissue lesions of difference frequency in dual-frequency high-intensity focused ultrasound (HIFU),' Ultrason Sonochem, vol. 13, pp. 339-44, May 2006. [28] A. H. Barati, M. Mokhtari-Dizaji, H. Mozdarani, Z. Bathaie, and Z. M. Hassan, 'Effect of exposure parameters on cavitation induced by low-level dual-frequency ultrasound,' Ultrason Sonochem, vol. 14, pp. 783-9, Sep 2007. [29] M. A. Bellavance, M. Blanchette, and D. Fortin, 'Recent advances in blood-brain barrier disruption as a CNS delivery strategy,' AAPS J, vol. 10, pp. 166-77, 2008. [30] N. Vykhodtseva, N. McDannold, and K. Hynynen, 'Progress and problems in the application of focused ultrasound for blood-brain barrier disruption,' Ultrasonics, Apr 14 2008. [31] K. A. Kadel, D. D. Heistad, and F. M. Faraci, 'Effects of endothelin on blood vessels of the brain and choroid plexus,' Brain Res, vol. 518, pp. 78-82, Jun 4 1990. [32] M. A. Maktabi, D. D. Heistad, and F. M. Faraci, 'Effects of angiotensin II on blood flow to choroid plexus,' Am J Physiol, vol. 258, pp. H414-8, Feb 1990. [33] K. M. Dziegielewska, J. Ek, M. D. Habgood, and N. R. Saunders, 'Development of the choroid plexus,' Microsc Res Tech, vol. 52, pp. 5-20, Jan 1 2001. [34] D. F. Emerich, S. J. Skinner, C. V. Borlongan, A. V. Vasconcellos, and C. G. Thanos, 'The choroid plexus in the rise, fall and repair of the brain,' Bioessays, vol. 27, pp. 262-74, Mar 2005. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40418 | - |
dc.description.abstract | 前人研究指出利用聚焦式超音波結合超音波顯影劑能非侵入地開啟特定區域的血腦屏障。本研究探討以單頻與共焦雙頻超音波配合超音波顯影劑開啟局部血腦屏障的差異。單頻超音波頻率為518kHz,雙頻超音波頻率為513kHz+523kHz,設定最大負聲壓值相近,重複頻率為1Hz,脈衝長度為10ms。以水診器量測單頻與雙頻訊號,得到壓力分佈狀態。超音波施打於雄性大白鼠右側大腦,開啟此處血腦屏障,並以Evans Blue滲出作為定量。另外,施予單頻超音波,給予不同劑量顯影劑,期望能找出一個最佳化的參數將傷害降到最低,並以核磁共振造影配合Gd-DTPA觀測血腦屏障開啟,期望能找到核磁共振造影影像與Evans Blue萃取之關係。
單頻與雙頻超音波對於Evans Blue滲出總量並沒有明顯差異,但Evans Blue分佈卻有些不同。推測由於脈衝長度太短導致雙頻並沒有明顯增加血腦屏障開啟。此外,由實驗得知壓力的分佈與血腦屏障開啟範圍的確有所關連,雙頻造成血腦屏障開啟的範圍的確大於單頻造成的範圍。在尋找最佳化參數實驗中發現施打超音波20秒給予超音波顯影劑劑量10μl/kg為最佳參數,在此參數下能夠只開啟聚焦區域的血腦屏障,並且幾乎不會造成出血情況產生。以核磁共振造影監測此實驗能得到影像與Evans Blue萃取相關性極高,以T1-weighted SE影像變化與Evans Blue作分析得到相關係數高達0.911;以T1-weighted GE影像變化與Evans Blue作分析得到相關係數高達0.981。結果表示能以核磁共振造影影像來代替傳統萃取的結果,能更有效率地即時得到物質滲入血腦屏障的變化。 | zh_TW |
dc.description.abstract | It has been shown that focused ultrasound (FUS) could disrupt local blood-brain barrier (BBB) noninvasively via the injection of ultrasound contrast agent (UCA). In this study, we use single frequency (518kHz) ultrasound and confocal dual frequency (513kHz+523kHz) ultrasound with the injection of UCA to disrupt the local BBB. Single frequency ultrasound and dual frequency ultrasound were set at almost the same acoustic negative peak pressure, and the pulse length was 10 ms. The brain of male Wistar rats were sonicated by ultrasound with the injection of UCA. The BBB disruption was evaluated by the extravasation of Evans Blue (EB). Additionally, we try out to find the optimal ultrasound parameters without producing hemorrhage, we use single frequency ultrasound with different doses of UCA. Expect this parameter could apply on future application.
There was no difference at the total extravasation amount of EB between single and dual frequency ultrasound, but the EB distribution were slightly different. Because of the short duty cycle (1%), the enhancement of cavitation effect produced by dual frequency was not obvious. In addition, the BBBD area was related to the pressure distribution. The BBBD area produced by dual frequency ultrasound was larger than single frequency ultrasound. We optimize the ultrasound parameter to 20s sonication with 10μl/kg ultrasound contrast agent dose, in this case, we could open the BBB precisely on the focal region and cause nearly no hemorrhage. When the MR enhancement was quantitatively evaluated by the EB extravasation, the correlation was very high. When it went to T1-weighted SE, the correlation coefficient between them was 0.911 (p < 0.01). When it went to T1-weighted GE, the correlation coefficient between them was 0.981 (p < 0.01). In our result, we could use MR images to take the place of EB extravasation, and we could monitor the penetration of drugs or molecules in time. | en |
dc.description.provenance | Made available in DSpace on 2021-06-14T16:47:08Z (GMT). No. of bitstreams: 1 ntu-97-R95548056-1.pdf: 4887168 bytes, checksum: 3cd5095c0334cf05b5912e4b05dd6657 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 致謝 I
摘要 II Abstract III 目錄 V 圖目錄 VII 表目錄 VIII Chapter 1緒論 1 1.1血腦屏障 1 1.1.1血腦屏障的定義 1 1.1.2血腦屏障的運輸 2 1.1.2.1小分子的被動擴散 2 1.1.2.2大分子的主動運輸 2 1.1.3 透過血腦屏障的運輸策略 2 1.2聚焦式超音波 3 1.2.1溫升效應 3 1.2.2空蝕化效應 4 1.2.3超音波開啟血腦屏障 4 1.2.4聚焦式超音波搭配超音波顯影劑開啟血腦屏障 4 1.2.5參數造成的影響 5 1.2.6血腦屏障開啟的物理機制 6 1.2.7血腦屏障開啟的生物機制 6 1.2.8血腦屏障開啟時間 7 1.3研究動機 8 1.3.1雙頻共焦式超音波 8 1.3.2尋找開啟血腦屏障的最佳參數 8 Chapter 2材料與方法 15 2.1單頻與雙頻訊號的量測裝置 15 2.2動物實驗 16 2.2.1動物麻醉及手術 16 2.2.2超音波設備 16 2.2.3超音波施打參數 18 2.2.4超音波顯影劑 18 2.2.5血腦屏障開啟評估 19 2.2.6 Evans Blue萃取流程 19 2.2.7萃取統計 20 2.2.8 H&E染色 20 Chapter 3實驗結果 28 3.1超音波探頭焦點位置 28 3.2單頻與雙頻訊號 28 3.3單頻與雙頻壓力分佈情形 28 3.3.1 X-Y 平面 28 3.3.2 X-Z 平面 29 3.4動物實驗結果 29 3.4.1單頻與雙頻超音波施打60秒,給予不同顯影劑劑量 29 3.4.2單頻與雙頻超音波施打20秒,給予不同顯影劑劑量 30 3.4.3單頻超音波施打20秒,給予不同顯影劑劑量 30 3.5 Evans Blue萃取結果 31 Chapter 4 討論 49 Chapter 5 未來展望 54 參考文獻 55 附錄一 60 | |
dc.language.iso | zh-TW | |
dc.title | 單頻與共焦雙頻聚焦式超音波配合超音波顯影劑應用於局部血腦屏障開啟之探討 | zh_TW |
dc.title | Investigation of Single Frequency and Confocal Dual Frequency Focused Ultrasound with Contrast Agent on Local Blood-Brain Barrier Disruption | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 符文美,曾文毅,劉浩澧,謝松蒼 | |
dc.subject.keyword | 聚焦式超音波,超音波顯影劑,血腦屏障,單頻,雙頻,核磁共振造影, | zh_TW |
dc.subject.keyword | Focused ultrasound,Ultrasound contrast agent,Blood-brain barrier,Single frequency,Dual frequency,MR images, | en |
dc.relation.page | 62 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-31 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 4.77 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。